Cancer Center Amsterdam
-
Serum levels of iCAF-derived osteoglycin predict favorable outcome in pancreatic cancer
Dings, M. P. G., Manoukian, P., Waasdorp, C., Quik, J. S. E., Strijker, M., Lodestijn, S. C., van Neerven, S. M., Moreno, L. F., de Oliveira, R. L., Bonsing, B. A., Bruno, M. J., Busch, O. R., Doukas, M., van Eijck, C. H., Mohammad, N. H., de Hingh, I. H., Molenaar, Q. I., Besselink, M. G., Vermeulen, L., Medema, J. P., & 2 others, 1 Feb 2023, In: International Journal of Cancer. 152, 3, p. 511-523 13 p.Research output: Contribution to journal › Article › Academic › peer-review
-
Impact of classical and basal-like molecular subtypes on overall survival in resected pancreatic cancer in the SPACIOUS-2 multicentre study
Dutch Pancreatic Cancer Group, 14 Oct 2022, In: The British journal of surgery. 109, 11, p. 1150-1155 6 p.Research output: Contribution to journal › Article › Academic › peer-review
-
Development and external validation of a prediction model for overall survival after resection of distal cholangiocarcinoma
Dutch Pancreatic Cancer Group (DPCG), 18 May 2022, In: British journal of cancer. 126, 9, p. 1280-1288 9 p.Research output: Contribution to journal › Article › Academic › peer-review
- All publications